Can Roche's Blockbuster Drug Herceptin's Sales Grow?

Roche Holding's (NASDAQ:RHHBY) Herceptin is the leading targeted therapy for the treatment of metastatic HER2 positive breast cancer. HER2 positive breast cancer refers to a type of breast cancer, in which the cells have higher than normal levels of HER2, which is a protein called human epidermal...